Hyperinsulinemia induced by highly active antiretroviral therapy in an adolescent with polycystic ovary syndrome who was infected with human immunodeficiency virus

Alessandra Viganò, Paola Manzoni, Silvia Riva, Paolo Brambilla, Enrico Ferrazzi, Marco M. Marzi

Research output: Contribution to journalArticle

Abstract

Objective: To report a case of polycystic ovary syndrome (PCOS) in an adolescent infected with human immunodeficiency virus (HIV) and lipodystrophy whose insulin resistance was induced by highly active antiretroviral therapy (HAART). Design: Case report. Setting: Academic department of pediatrics. Patient(s): A 14-year-old vertically HIV-infected adolescent receiving HAART. Intervention(s): Clinical observation, metabolic and endocrinologic assessment, imaging of ovaries by ultrasound, and of intra-abdominal adipose tissue content by magnetic resonance imaging. Main Outcome Measure(s): Lipodystrophy, insulin resistance, PCOS. Result(s): After 34 months of HAART this adolescent showed lipodystrophy with central obesity and insulin resistance after oral glucose tolerance test (OGTT). Ovaries were normal at ultrasonography. After 56 weeks of HAART, the adolescent showed more severe evidence of lipodystrophy and insulin resistance, and she developed acne, hirsutism, and amenorrhea. The following hormone levels were elevated: FSH 5.9 mUI/mL, LH 15.4 mUI/mL, LH/FSH ratio >2.5, free T 5.6 pg/mL, DHEAS 2,070 ng/mL, androstenedione (A) 3.42 ng/mL; whereas 17-β-E2, P, PRL, and free T4 values were within the normal range. Ultrasonography demonstrated a typical polycystic echographic architecture of the ovaries. Conclusion(s): Lipodystrophy and insulin resistance are well-recognized side effects of HAART. Polycystic ovary syndrome might be an additional side effect secondary to insulin resistance and lipodystrophy.

Original languageEnglish
Pages (from-to)422-423
Number of pages2
JournalFertility and Sterility
Volume79
Issue number2
DOIs
Publication statusPublished - Feb 1 2003

Fingerprint

Lipodystrophy
Polycystic Ovary Syndrome
Highly Active Antiretroviral Therapy
Hyperinsulinism
Insulin Resistance
HIV
Ovary
Ultrasonography
Hirsutism
Intra-Abdominal Fat
Abdominal Obesity
Androstenedione
Amenorrhea
Acne Vulgaris
Glucose Tolerance Test
Reference Values
Magnetic Resonance Imaging
Observation
Outcome Assessment (Health Care)
Hormones

Keywords

  • HAART
  • Hyperinsulinism
  • Lipodystrophy
  • PCOS
  • Pediatric HIV infection

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Hyperinsulinemia induced by highly active antiretroviral therapy in an adolescent with polycystic ovary syndrome who was infected with human immunodeficiency virus. / Viganò, Alessandra; Manzoni, Paola; Riva, Silvia; Brambilla, Paolo; Ferrazzi, Enrico; Marzi, Marco M.

In: Fertility and Sterility, Vol. 79, No. 2, 01.02.2003, p. 422-423.

Research output: Contribution to journalArticle

Viganò, Alessandra ; Manzoni, Paola ; Riva, Silvia ; Brambilla, Paolo ; Ferrazzi, Enrico ; Marzi, Marco M. / Hyperinsulinemia induced by highly active antiretroviral therapy in an adolescent with polycystic ovary syndrome who was infected with human immunodeficiency virus. In: Fertility and Sterility. 2003 ; Vol. 79, No. 2. pp. 422-423.
@article{ef094a7ca84146109c481990e4441241,
title = "Hyperinsulinemia induced by highly active antiretroviral therapy in an adolescent with polycystic ovary syndrome who was infected with human immunodeficiency virus",
abstract = "Objective: To report a case of polycystic ovary syndrome (PCOS) in an adolescent infected with human immunodeficiency virus (HIV) and lipodystrophy whose insulin resistance was induced by highly active antiretroviral therapy (HAART). Design: Case report. Setting: Academic department of pediatrics. Patient(s): A 14-year-old vertically HIV-infected adolescent receiving HAART. Intervention(s): Clinical observation, metabolic and endocrinologic assessment, imaging of ovaries by ultrasound, and of intra-abdominal adipose tissue content by magnetic resonance imaging. Main Outcome Measure(s): Lipodystrophy, insulin resistance, PCOS. Result(s): After 34 months of HAART this adolescent showed lipodystrophy with central obesity and insulin resistance after oral glucose tolerance test (OGTT). Ovaries were normal at ultrasonography. After 56 weeks of HAART, the adolescent showed more severe evidence of lipodystrophy and insulin resistance, and she developed acne, hirsutism, and amenorrhea. The following hormone levels were elevated: FSH 5.9 mUI/mL, LH 15.4 mUI/mL, LH/FSH ratio >2.5, free T 5.6 pg/mL, DHEAS 2,070 ng/mL, androstenedione (A) 3.42 ng/mL; whereas 17-β-E2, P, PRL, and free T4 values were within the normal range. Ultrasonography demonstrated a typical polycystic echographic architecture of the ovaries. Conclusion(s): Lipodystrophy and insulin resistance are well-recognized side effects of HAART. Polycystic ovary syndrome might be an additional side effect secondary to insulin resistance and lipodystrophy.",
keywords = "HAART, Hyperinsulinism, Lipodystrophy, PCOS, Pediatric HIV infection",
author = "Alessandra Vigan{\`o} and Paola Manzoni and Silvia Riva and Paolo Brambilla and Enrico Ferrazzi and Marzi, {Marco M.}",
year = "2003",
month = "2",
day = "1",
doi = "10.1016/S0015-0282(02)04693-9",
language = "English",
volume = "79",
pages = "422--423",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Hyperinsulinemia induced by highly active antiretroviral therapy in an adolescent with polycystic ovary syndrome who was infected with human immunodeficiency virus

AU - Viganò, Alessandra

AU - Manzoni, Paola

AU - Riva, Silvia

AU - Brambilla, Paolo

AU - Ferrazzi, Enrico

AU - Marzi, Marco M.

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Objective: To report a case of polycystic ovary syndrome (PCOS) in an adolescent infected with human immunodeficiency virus (HIV) and lipodystrophy whose insulin resistance was induced by highly active antiretroviral therapy (HAART). Design: Case report. Setting: Academic department of pediatrics. Patient(s): A 14-year-old vertically HIV-infected adolescent receiving HAART. Intervention(s): Clinical observation, metabolic and endocrinologic assessment, imaging of ovaries by ultrasound, and of intra-abdominal adipose tissue content by magnetic resonance imaging. Main Outcome Measure(s): Lipodystrophy, insulin resistance, PCOS. Result(s): After 34 months of HAART this adolescent showed lipodystrophy with central obesity and insulin resistance after oral glucose tolerance test (OGTT). Ovaries were normal at ultrasonography. After 56 weeks of HAART, the adolescent showed more severe evidence of lipodystrophy and insulin resistance, and she developed acne, hirsutism, and amenorrhea. The following hormone levels were elevated: FSH 5.9 mUI/mL, LH 15.4 mUI/mL, LH/FSH ratio >2.5, free T 5.6 pg/mL, DHEAS 2,070 ng/mL, androstenedione (A) 3.42 ng/mL; whereas 17-β-E2, P, PRL, and free T4 values were within the normal range. Ultrasonography demonstrated a typical polycystic echographic architecture of the ovaries. Conclusion(s): Lipodystrophy and insulin resistance are well-recognized side effects of HAART. Polycystic ovary syndrome might be an additional side effect secondary to insulin resistance and lipodystrophy.

AB - Objective: To report a case of polycystic ovary syndrome (PCOS) in an adolescent infected with human immunodeficiency virus (HIV) and lipodystrophy whose insulin resistance was induced by highly active antiretroviral therapy (HAART). Design: Case report. Setting: Academic department of pediatrics. Patient(s): A 14-year-old vertically HIV-infected adolescent receiving HAART. Intervention(s): Clinical observation, metabolic and endocrinologic assessment, imaging of ovaries by ultrasound, and of intra-abdominal adipose tissue content by magnetic resonance imaging. Main Outcome Measure(s): Lipodystrophy, insulin resistance, PCOS. Result(s): After 34 months of HAART this adolescent showed lipodystrophy with central obesity and insulin resistance after oral glucose tolerance test (OGTT). Ovaries were normal at ultrasonography. After 56 weeks of HAART, the adolescent showed more severe evidence of lipodystrophy and insulin resistance, and she developed acne, hirsutism, and amenorrhea. The following hormone levels were elevated: FSH 5.9 mUI/mL, LH 15.4 mUI/mL, LH/FSH ratio >2.5, free T 5.6 pg/mL, DHEAS 2,070 ng/mL, androstenedione (A) 3.42 ng/mL; whereas 17-β-E2, P, PRL, and free T4 values were within the normal range. Ultrasonography demonstrated a typical polycystic echographic architecture of the ovaries. Conclusion(s): Lipodystrophy and insulin resistance are well-recognized side effects of HAART. Polycystic ovary syndrome might be an additional side effect secondary to insulin resistance and lipodystrophy.

KW - HAART

KW - Hyperinsulinism

KW - Lipodystrophy

KW - PCOS

KW - Pediatric HIV infection

UR - http://www.scopus.com/inward/record.url?scp=0037307318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037307318&partnerID=8YFLogxK

U2 - 10.1016/S0015-0282(02)04693-9

DO - 10.1016/S0015-0282(02)04693-9

M3 - Article

C2 - 12568857

AN - SCOPUS:0037307318

VL - 79

SP - 422

EP - 423

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 2

ER -